Biology News
Evolution Runs Faster on Short Timescales - Quanta Magazine


Quanta Magazine
Then, in the mid-2000s, Simon Ho, an evolutionary biologist at the University of Sydney, encountered a similar phenomenon in the genomes he was analyzing. When he calculated how quickly DNA mutations accumulated in birds and primates over just a few ...

Quanta BioDesign, Ltd.

Ohio - United States

Quanta BioDesign, Ltd. was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs. The company was founded in 1997 by Paul D. Davis, Ph.D. under the name BioOrganic Technologies, LLC. In the spring of 1999 the name was changed to Quanta BioDesign, Ltd., to better reflect the company’s mission.

  • Category:

    Biotechnology

  • Image:

  • Description:

    Quanta BioDesign, dPEG, dPEG, discrete PEG
    Quanta BioDesign is a leading supplier of dPEG® used in modification of therapeutic macromolecules, linkers in antibody-drug conjugates, bioconjugation, and surface modification

  •  

    Drug Discovery - Peptide Synthesis - Nanotechnology

Related
Quanta BioDesign,Ltd.
United States

Research and manufacturing company offering a full range of discrete polyethylene glycol pegylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis and nanotechnology.

Biodesign International
United States

Catalog and specification of supplies of antibodies, antigens, such as aflatoxin alpha-2-macroglobulin, amphetamine annexin VI, atrial natriuetic peptide (ANP) and cGMP pharmaceutical services in Saco, Maine.